Why Healthscope Ltd shares could be at bargain prices

Is the Healthscope Ltd (ASX:HSO) share price a bargain or value trap?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Healthscope Ltd (ASX: HSO)  is the second-largest provider of private hospital services in Australia and a leading provider of pathology services in New Zealand, Malaysia, and Singapore. 

Over the last 12 months, its share price has plunged 46% to $1.67 following two major announcements made by the company.  

Firstly, in October 2016, Healthscope announced that it was experiencing weaker-than-expected volumes which would translate to flat earnings growth for the year when annualised.

At that point, consensus analyst forecasts were anticipating at least 10% growth.  Subsequently, the full year FY 2017 results showed that the Group's operating net profit after tax from continuing operations was down 5.6% to $180m.  

Secondly, in August 2017, the company announced the sale of its medical centres for $55m, a massive discount to book value which resulted in a non-cash impairment loss of $54.7m in relation to the sale.

The medical centres had contributed approximately 2% of Group operating EBITDA in the first half of FY 2017 and following a strategic review, management felt that it was better to dispose them and focus on the core hospital & international pathology operations.  

Overreaction? 

If you are wondering how these two announcements could lead to Healthscope losing close to half its market capitalisation, you wouldn't be alone.

The defensive nature of the healthcare sector is well understood. We all need good quality healthcare and the long-term macro trend of an ageing population means that in the long run, there is an expectation that there will be increased demand for the services of private healthcare operators.

This expectation is why the healthcare stocks tend to have very high price-to-earnings multiples and when there are indicators that this expectation might not be met, the market tends to react quite harshly. 

Warren Buffett's mentor  Benjamin Graham, in his book 'The Intelligent Investor' conceptualised the stock market as a business partner named Mr Market who approaches investors on a daily basis with a quote at which they can buy or sell a security. He characterised Mr Market as a very moody individual. On some days, he is quite euphoric and offers up a very high price. On other days, he is quite depressed and quotes very low. To me, this is what appears to be happening with Healthscope.

Foolish takeaway 

Despite the short-term challenges, the long-term prospects for Healthscope appear to be favourable: 

  • There is likely to be long-term demand for private health care due to an ageing population and the government's support for private health operators via the Medicare levy surcharge.  
  • Healthscope continues to pursue growth through brownfield hospital expansion projects.  
  • Healthscope has a strong balance sheet with freehold ownership of 30 of its hospitals.
Motley Fool contributor Kevin Gandiya has no financial interest in any company mentioned. You can find Kevin on Twitter @kevingandiya  The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »